126 related articles for article (PubMed ID: 24670448)
1. [Expression of plasma miR-106a in colorectal cancer and its clinical significance].
Zhang L; Meng L; Fan Z; Liu B; Pei Y; Zhao Z
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Mar; 34(3):354-7. PubMed ID: 24670448
[TBL] [Abstract][Full Text] [Related]
2. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
3. Fecal miR-106a is a useful marker for colorectal cancer patients with false-negative results in immunochemical fecal occult blood test.
Koga Y; Yamazaki N; Yamamoto Y; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1844-52. PubMed ID: 23950216
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
5. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic significance of miR-106a in gastric cancer.
Hou X; Zhang M; Qiao H
Int J Clin Exp Pathol; 2015; 8(10):13096-101. PubMed ID: 26722506
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
[TBL] [Abstract][Full Text] [Related]
8. [Serum miR-103 as a potential diagnostic biomarker for breast cancer].
Wang X; Wu X; Yan L; Shao J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):631-4. PubMed ID: 22588912
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
[TBL] [Abstract][Full Text] [Related]
10. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
[TBL] [Abstract][Full Text] [Related]
11. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
12. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ
Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727
[TBL] [Abstract][Full Text] [Related]
13. Similarly up-regulated microRNA-106a in matched formalin-fixed paraffin-embedded and fresh frozen samples and the dynamic changes during gastric carcinogenesis and development.
Zhu M; Zhang N; He S
Pathol Res Pract; 2014 Dec; 210(12):909-15. PubMed ID: 25115709
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated Circulating miR-106a by DNA Methylation Promised a Potential Diagnostic and Prognostic Marker for Gastric Cancer.
Yuan R; Wang G; Xu Z; Zhao H; Chen H; Han Y; Wang B; Zhou J; Hu H; Guo Z; Shen H; Xue X
Anticancer Agents Med Chem; 2016; 16(9):1093-100. PubMed ID: 26179261
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
[TBL] [Abstract][Full Text] [Related]
16. Serum miR-92a-1 is a novel diagnostic biomarker for colorectal cancer.
Shi Y; Liu Z
J Cell Mol Med; 2020 Aug; 24(15):8363-8367. PubMed ID: 32562465
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
19. [Study on miR-490-5p and miR-363 as novel biomarkers for the diagnosis of colorectal cancer].
Xu X; Wu X; Wu S; Jiang Q; Liu H; Chen R; Sun Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):45-50. PubMed ID: 24519049
[TBL] [Abstract][Full Text] [Related]
20. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
